Its unique dual action as a GIP and GLP-1 receptor agonist makes it stand out from other weight management agents, offering enhanced efficacy in regulating blood sugar and supporting fat loss
Minerva Endocrinol (Torino) 2023;48(2):206213
Other Benefits and Risks In addition to helping with weight loss and diabetes, GLP-1 medications may also have other potential benefits, such as: Cardiovascular protection : They may reduce the risk of heart attacks and strokes , particularly in people with diabetes
What are the potential adverse effects of glutathione supplementation?
Therefore, Monjourno and Tirzepatide refer to the same medication
BPC 157 has been studied for its effects on tendon, ligament, muscle, and bone healing